Characteristics of participants
| Characteristic | Type 1 DM (n=15) | Type 2 DM (n=14) |
|---|---|---|
| Men/women | 6/9 | 8/6 |
| Age, years | Mean 45.7 (±16.4), range 22–64 | Mean 63.7 (±10.4), range 44–81 |
| 18–30 | 4 | 0 |
| 31–40 | 1 | 0 |
| 41–50 | 3 | 2 |
| 51–60 | 3 | 3 |
| 61–70 | 4 | 6 |
| >70 | 0 | 3 |
| Diabetes duration years | Mean 22.7 (±13.9), range 6–50 | Mean 13.4 (±5.0), range 5–23 |
| No pharmacological treatment for diabetes | 0 | 1 |
| Oral antidiabetes drugs | 0 | 4 |
| Insulin | 15 | 1 |
| Whereof insulin pump | 7 | 0 |
| Combined treatment (eg, tablets, insulin, incretine) | 0 | 8 |
| HbA1c average over the past 2 years: mmol/mol | Mean 62 (±11), range 42–80 | Mean 59 (±14), range 41–83 |
| <53 | 2 | 5 |
| 53–65 | 4 | 7 |
| >65 | 6 | 5 |
| BMI average over the past 2 years | Mean 26.6 (±5.2), range 16.8–35.5 | Mean 29.4 (±19.7), range 23.0–38.3 |
| <18.5 | 1 | 0 |
| 18.5–24.9 | 5 | 4 |
| 25.0–29.9 | 4 | 5 |
| >29.9 | 4 | 6 |
| Hospital-based outpatient clinic | 14 | 1 |
| Primary healthcare clinic | 1 | 13 |
BMI, body mass index; DM, diabetes mellitus; HbA1c, glycated haemoglobin.